Senate Majority Leader Raises Concerns Over Tylenol and Autism Link

On Wednesday, Senate Majority Leader John Thune voiced his concerns regarding the Trump administration’s suggestion that using Tylenol during pregnancy may be linked to autism in children. He seems genuinely worried about how this warning might affect women.

Thune (R-SD) expressed skepticism about the claims made by President Trump and HHS Secretary Robert F. Kennedy Jr. while appearing on CNN’s “Inside Politics.” He questioned whether the evidence they cited actually supports their assertions about the widely used pain reliever.

When asked by CNN’s Dana Bash if he believed Monday’s announcement could negatively impact the health of expectant mothers and their babies, Thune responded, “Well, I’m obviously very concerned about that.”

He emphasized that discussions and decisions about health should be guided by scientific evidence. “There are studies they mention, but again, I think there are so many people in the medical community who believe the conclusion about Tylenol might be different,” he added.

Thune cautioned against making sweeping statements, urging that any claims need to be supported by solid scientific backing and expert consultations: “We must ensure all of this is well documented.”

Recently, Trump, RFK Jr., and other officials announced that acetaminophen, the active ingredient in Tylenol, could “really increase the risk of autism.” They referenced several studies, suggesting that using acetaminophen, especially late in pregnancy, might lead to long-term neurological effects in children.

However, while the studies indicate a potential association between acetaminophen use and autism, they do not clearly establish a direct link between the drug and neurodevelopmental disorders.

On Monday, Trump advised pregnant women to “Don’t take Tylenol” in light of these findings. This sentiment was met with pushback from Kamb, the maker of Tylenol, which stated it was “strongly opposed” to the claims being made by the administration.

Dr. Kamb noted, “Secretaries have a responsibility to restore Americans’ trust in the decision-making process, and this should be founded on science.”

Thune added that the decision-making process needs to be monitored, accountable, and transparent, insisting that science should be at the forefront.

On Tuesday, Senator Bill Cassidy, a licensed physician who chairs the Senate Committee overseeing health care policy, echoed these concerns. He mentioned that the prevailing evidence does not support a strong link between acetaminophen and increased autism diagnoses. Cassidy asked Kennedy to provide the data that the Trump administration used to support its claims, arguing it’s critical for women to have options for managing pain during pregnancy. “We need to be considerate of this issue,” he reiterated.